Osiris therapeutics, inc. (OSIR)
Balance Sheet / Yearly
Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current Assets
Cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,208

946

2,658

2,342

2,416

1,801

1,579

1,287

-

-

-

-

-

-

-

-

Cash and cash equivalents

16,367

31,658

23,071

3,363

3,081

3,234

1,625

1,161

2,833

3,287

3,551

5,516

9,144

17,765

2,241

3,800

-

-

-

-

-

-

-

-

1,854

1,056

1,109

1,586

1,661

1,403

1,510

1,442

Certificates of deposit

10,044

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

8,276

8,701

-

-

24,807

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Estimated Fair Value

-

-

9,303

24,503

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

-

-

-

-

-

28,540

20,538

21,427

23,829

25,999

26,662

26,583

24,809

22,517

36,420

35,257

37,305

42,349

45,759

34,650

39,508

26,464

25,626

28,292

32,238

36,159

37,637

41,618

45,730

50,454

54,650

66,166

Trading securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,591

15,060

15,584

16,907

17,086

-

-

-

-

-

-

-

-

-

-

-

Trade receivables, net

22,469

20,592

23,534

26,522

26,053

22,028

23,414

23,014

23,248

20,928

20,125

18,850

18,799

17,901

16,190

13,690

13,373

12,512

9,291

8,627

7,459

6,773

6,406

5,346

2,854

2,231

1,393

997

728

1,460

1,643

1,928

Other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,081

623

472

15,346

15,369

104

104

104

5

-

-

-

-

-

-

-

Inventory, net

9,614

10,576

11,118

11,016

11,278

12,414

11,633

11,199

11,366

10,344

9,785

10,371

9,577

9,472

9,350

9,267

9,824

7,867

5,353

3,249

1,929

1,682

1,866

1,843

1,278

922

475

415

767

729

623

510

Insurance receivable

-

4,788

4,788

4,788

4,788

4,788

4,788

4,788

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,188

2,188

2,192

2,192

3,170

Prepaid expenses and other current assets

3,477

3,421

2,876

3,078

2,920

3,542

3,735

3,568

3,221

4,206

4,036

4,219

4,321

5,312

5,467

11,289

2,894

2,234

1,444

480

355

639

356

462

603

1,062

3,371

636

344

762

743

736

Current assets of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

96

91

247

-

-

204

-

-

-

-

-

-

-

Total current assets

70,247

79,736

74,690

73,270

72,927

74,546

65,733

65,157

64,497

64,764

64,159

65,539

66,650

76,057

77,968

81,465

86,276

81,591

80,561

81,697

84,213

37,710

35,937

37,334

39,036

41,430

43,985

47,440

51,418

57,000

61,361

73,952

Property and equipment, net

2,882

3,116

3,295

3,476

3,587

2,467

2,242

2,281

2,390

2,478

2,066

2,113

2,077

2,070

2,141

2,176

2,079

2,004

1,895

1,809

1,896

2,009

2,040

2,037

2,111

2,220

2,153

2,306

2,463

2,646

2,792

3,127

Deferred income taxes, net

25,205

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Insurance receivable

-

-

-

-

-

-

-

-

4,788

4,788

4,788

4,788

4,788

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,796

5,849

-

-

-

-

-

-

-

-

-

-

-

Other assets

-

-

-

-

-

103

137

137

142

164

152

152

151

95

95

95

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

223

243

243

243

317

317

317

318

392

392

392

392

521

521

Other assets

3,168

1,849

1,842

1,831

1,608

-

-

-

-

-

-

-

-

-

-

-

95

96

-

-

-

-

-

-

-

-

-

-

-

19

35

184

Total assets

101,502

84,701

79,827

78,577

78,122

77,116

68,112

67,575

71,817

72,194

71,165

72,592

73,666

78,222

80,204

83,736

88,450

83,691

82,679

89,545

92,201

39,962

38,294

39,688

41,464

43,968

46,530

50,138

54,273

60,057

64,709

77,784

Liabilities and Equity
Current liabilities
Accounts payable

4,144

4,291

5,452

5,843

5,269

5,014

3,713

3,936

5,559

5,977

5,543

4,515

4,749

4,224

2,575

4,437

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

13,820

10,704

10,023

11,039

9,399

9,991

10,352

9,766

11,001

9,303

10,508

9,454

7,321

8,370

7,547

5,787

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued shareholder litigation

900

19,400

18,500

18,500

18,500

18,500

18,500

18,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,468

6,591

5,870

3,135

4,842

3,652

6,826

4,985

2,096

5,002

5,166

4,804

4,692

5,613

4,386

5,569

Other current liabilities

1,728

1,994

1,739

1,764

1,934

2,066

1,878

1,960

1,816

1,850

1,650

1,663

1,791

1,517

1,618

1,398

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital lease obligations, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

45

45

45

45

45

45

45

44

44

44

-

-

-

-

-

-

Deferred exclusivity fee revenue, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,667

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,796

5,849

-

-

-

-

-

-

-

-

-

-

-

Current liabilities of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17

57

463

-

-

2,903

-

-

-

-

-

-

-

Deferred revenue, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,333

13,573

23,813

40,960

Total current liabilities

20,592

36,389

35,714

37,146

35,102

35,571

34,443

34,162

18,376

17,130

17,701

15,632

13,861

21,001

11,740

11,622

9,180

6,636

5,915

8,993

10,793

7,702

7,555

6,089

5,043

5,046

5,166

4,804

8,025

19,186

28,199

46,529

Accrued shareholder litigation

-

-

-

-

-

-

-

-

18,500

18,500

18,500

18,500

18,500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term portion of capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

173

-

-

-

-

-

-

Deferred revenue, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,333

Other long-term liabilities

2,382

2,450

2,433

2,497

1,626

1,953

1,817

2,134

2,440

2,751

2,623

2,940

4,763

3,588

3,910

4,228

3,589

276

280

319

355

433

469

501

531

387

405

419

430

442

453

465

Total liabilities

22,974

38,839

38,147

39,643

36,728

37,524

36,260

36,296

39,316

38,381

38,824

37,072

37,124

24,589

15,650

15,850

12,769

6,912

6,195

9,312

11,148

8,135

8,024

6,590

5,574

5,606

5,571

5,223

8,455

19,628

28,652

50,327

Commitments and contingencies

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

-

-

-

0

-

-

-

Equity
Common stock, $0.001 par value, 72,000 shares authorized, 34,527 shares issued and outstanding at December 31, 2018, and 90,000 shares authorized, 34,526 shares issued and outstanding at December 31, 2017

35

35

35

35

35

35

35

35

35

35

35

35

35

35

35

35

35

35

34

34

34

34

33

33

33

33

33

33

33

33

33

33

Additional paid-in-capital

284,189

284,124

284,049

283,976

283,905

283,856

283,854

283,895

283,678

283,515

283,340

283,320

284,024

283,049

289,426

288,336

287,320

286,299

285,603

284,116

282,702

283,369

280,616

279,911

279,269

279,092

278,785

278,477

278,092

-

-

-

Additional paid-in-capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

277,749

277,381

274,646

Accumulated other comprehensive loss

-259

-330

-230

-419

-208

-55

-35

109

-89

163

192

83

-143

-94

-201

-143

-54

42

72

55

-33

-89

-86

5

-20

15

5

4

20

22

31

-3

Accumulated deficit

-205,437

-237,967

-242,174

-244,658

-242,338

-244,244

-252,002

-252,760

-251,123

-249,900

-251,226

-247,918

-247,374

-229,357

-224,706

-220,342

-211,620

-209,597

-209,225

-203,972

-201,650

-251,487

-250,293

-246,851

-243,392

-240,778

-237,864

-233,599

-232,327

-237,375

-241,388

-247,219

Total equity

78,528

45,862

41,680

38,934

41,394

39,592

31,852

31,279

32,501

33,813

32,341

35,520

36,542

53,633

64,554

67,886

75,681

76,779

76,484

80,233

81,053

31,827

30,270

33,098

35,890

38,362

40,959

44,915

45,818

40,429

-

27,457

Total stockholders' equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

36,057

-

Total liabilities and equity

101,502

84,701

79,827

78,577

78,122

77,116

68,112

67,575

71,817

72,194

71,165

72,592

73,666

78,222

80,204

83,736

88,450

83,691

82,679

89,545

92,201

39,962

38,294

39,688

41,464

43,968

46,530

50,138

54,273

60,057

64,709

77,784